On Sep 15, 2015, we issued an updated research report on Cyberonics Inc. CYBX – a Texas-based medical technology company with core expertise in neuromodulation. While it eagerly awaits the completion ...

Prior to the close of their proposed merger, Cyberonics, Inc. CYBX and Sorin S.p.A. have jointly announced their respective designees to the Board of Directors of the combined company that will come ...

Cyberonics, which makes a device that treats epilepsy, disclosed Monday it received a warning letter last month from the FDA citing problems inspectors found at its Houston manufacturing plant. The ...

NEW YORK (AP) -- Shares of Cyberonics Inc. rose Monday on news that a former employee had dropped his lawsuit against the neurological device maker. THE SPARK: Cyberonics said that Andrew Hagerty ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: The ...

Cyberonics, Inc. CYBX shares gained more than 20 percent after the company said it will merge with Italian-based Sorin SpA in a stock-swap valuing the two companies at $2.7 billion. Cyberonics changed ...

Look here for a clue. There's no foolproof way to know the future for Cyberonics (Nasdaq: CYBX) or any other company. However, certain clues may help you see potential stumbles before they happen -- ...

WASHINGTON - Cyberonics shares dropped Friday after a Senate panel questioned the Food and Drug Administration's approval of the Houston firm's implantable device for treating severe depression. The ...

HOUSTON, Feb. 25, 2015 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced it received CE (Conformite Europeenne) Mark of the VITARIA™ System for delivering autonomic regulation therapy ...

Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in ...

The tumultuous tenure of Robert P. Cummins as chairman, president and chief executive of the medical device maker Cyberonics has ended, the company disclosed yesterday. Mr. Cummins, 52, who is known ...

A group of Cyberonics shareholders led by Metropolitan Capital Advisors, which disclosed a 7.3 percent stake in the company, says it will press for the election of three board nominees. The ...